Lupin Irebesartan Recall Issued Over Cancer Causing N-nitrosoirbesartan Contamination
Nearly 80 lots of Irbesartan and Irbesartan/HCTZ combination tablets are being recalled due to the presence of a potentially cancer-causing chemical.
Tag Archives: Zantac
-
-
Class Action Claims to Monitor For Zantac Cancer Diagnosis Cleared To Proceed
A federal judge has ruled Zantac class action lawsuits calling for defendants to pay for the costs of medical monitoring for potential cancer, and to be held responsible for consumers'…
-
Zantac MDL Judge To Consider Motion to Dismiss Amended Medical Monitoring Class Action
A federal judge will hear arguments early next month on whether class action lawsuits calling for the makers of Zantac to pay for medical monitoring for consumers who may now…
-
Zantac Trial Scheduled To Begin October 2022 in California State Court Over Cancer Risk
A California state case may be the first Zantac cancer lawsuit to go before a jury in October 2022.
-
Valsartan Lawsuit Alleges Toxic Contamination Led to 8 Different Cancer Diagnoses
A valsartan lawsuit claims the recalled hypertension drug led to eight cancer diagnoses for a New York man.
-
Generic Valsartan Lawsuit Alleges NDMA Exposure Led To Prostate Cancer
A product liability lawsuit claims years of generic valsartan use led to the development of prostate cancer due to the presence of NDMA and other impurities.
-
Zantac Lawsuits Against GSK, Pfizer and Other Brand Drug Makers Survive Motions to Dimsiss
A federal judge has cleared the way for Zantac cancer lawsuits to proceed after rejecting an effort by defendants to have all the claims against them dismissed.
-
FDA Studies Question Whether Zantac Converts into Cancer-Causing Chemical In Human Body
Two new FDA studies raise questions about previous claims Zantac converts into a cancer-causing chemical in the human body.
-
Pfizer Suspends Chantix Distribution Due to Presence of Cancer-Causing NDMA
Pfizer has halted distribution of Chantix due to the potential presence of high levels of NDMA or other nitrosamines which could increase the risk of cancer.
-
Zantac Recall Lawsuit Expected To Go Before Jury For Bellwether Trial in 2023
The first Zantac bellwether trial is expected to go before juries sometime in mid-2023, according to a schedule issued by the federal judge overseeing the consolidated litigation.